Alina Robert, MD
Interventional Cardiology · Lebanon, NHNPI 1609042258
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Shockwave Medical, Inc at 44.2% of the total. 2025 is the largest year on record at $643, 4.6 times the $141 reported in 2023. That places this record below the midpoint for interventional cardiology clinicians in NH, where the typical reported total is $5,309.
Across 27 payments — averaging $38.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$458
- Boston Scientific$309
- Abiomed$178
- Heartflow, Inc.$90
Across 5 payments — averaging $5043.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$25K
What the payments were for
- Food & beverage$1,035100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 5 | $458 |
| Boston Scientific | 19 | $309 |
| Abiomed | 2 | $178 |
| Heartflow, Inc. | 1 | $90 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,035 in reported general payments places this provider in the 10th percentile of 26 interventional cardiology providers in New Hampshire.
See all interventional cardiology providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 120 | $119,738 |
| Repatha SureclickEvolocumab | 71 | $65,310 |
| FarxigaDapagliflozin Propanediol | 19 | $18,078 |
| JardianceEmpagliflozin | 25 | $17,907 |
| Repatha PushtronexEvolocumab | 22 | $12,963 |
| XareltoRivaroxaban | 13 | $6,648 |
| BrilintaTicagrelor | 12 | $5,212 |
| Metoprolol Succinate | 205 | $2,600 |
| Atorvastatin Calcium | 215 | $2,235 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 84 | $1,513 |
| Rosuvastatin Calcium | 88 | $950 |
| Ezetimibe | 57 | $946 |
| Carvedilol | 101 | $898 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 15 | $678 |
| Losartan Potassium | 75 | $567 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Lebanon
- Hannah ChaudryLebanon$20K
- Eric RothsteinLebanon$20K
- James DevriesLebanon$19K
- Aaron KaplanLebanon$13K
- Bruce FriedmanLebanon$1K
- John JayneLebanon$96
- John RobbLebanon$0
- Shahab MoossaviConcord$36K
- Nitish SharmaDover$23K
- Rodrigo Mendirichaga MaganaDover$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.